Differential impact of the HIV-1 non-nucleoside reverse transcriptase inhibitor mutations K103N and M230L on viral replication and enzyme function
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Differential impact of the HIV-1 non-nucleoside reverse transcriptase inhibitor mutations K103N and M230L on viral replication and enzyme function
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 65, Issue 11, Pages 2291-2299
Publisher
Oxford University Press (OUP)
Online
2010-09-19
DOI
10.1093/jac/dkq338
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Resistance profile of etravirine: combined analysis of baseline genotypic and phenotypic data from the randomized, controlled Phase III clinical studies
- (2010) Johan Vingerhoets et al. AIDS
- Combinations of Mutations in the Connection Domain of Human Immunodeficiency Virus Type 1 Reverse Transcriptase: Assessing the Impact on Nucleoside and Nonnucleoside Reverse Transcriptase Inhibitor Resistance
- (2010) S. Gupta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The M230L Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutation in HIV-1 Reverse Transcriptase Impairs Enzymatic Function and Viral Replicative Capacity
- (2010) H. T. Xu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro resistance development for RO-0335, a novel diphenylether nonnucleoside reverse transcriptase inhibitor
- (2010) H. Javanbakht et al. ANTIVIRAL RESEARCH
- Constrained patterns of covariation and clustering of HIV-1 non-nucleoside reverse transcriptase inhibitor resistance mutations
- (2010) Elizabeth C. Reuman et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Crystal Structures of HIV-1 Reverse Transcriptase with Etravirine (TMC125) and Rilpivirine (TMC278): Implications for Drug Design
- (2010) Eric B. Lansdon et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Novel Molecular Mechanism of Dual Resistance to Nucleoside and Nonnucleoside Reverse Transcriptase Inhibitors
- (2010) G. N. Nikolenko et al. JOURNAL OF VIROLOGY
- Nonnucleoside Reverse Transcriptase Inhibitor Resistance and the Role of the Second-Generation Agents
- (2009) Jessica Adams et al. ANNALS OF PHARMACOTHERAPY
- Factors Associated with Virological Response to Etravirine in Nonnucleoside Reverse Transcriptase Inhibitor-Experienced HIV-1-Infected Patients
- (2009) A.-G. Marcelin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Solution characterization of [methyl-13C]methionine HIV-1 reverse transcriptase by NMR spectroscopy
- (2009) Xunhai Zheng et al. ANTIVIRAL RESEARCH
- Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: A review of the last 20 years (1989–2009)
- (2009) Marie-Pierre de Béthune ANTIVIRAL RESEARCH
- Etravirine, a Next‐Generation Nonnucleoside Reverse‐Transcriptase Inhbitor
- (2009) Leonard B. Johnson et al. CLINICAL INFECTIOUS DISEASES
- Phenotypic impact of resistance mutations on etravirine susceptibility in HIV patients with prior failure to nonnucleoside analogues
- (2008) Eva Poveda et al. AIDS
- Impact of Residues in the Nonnucleoside Reverse Transcriptase Inhibitor Binding Pocket on HIV-1 Reverse Transcriptase Heterodimer Stability
- (2008) Anna Figueiredo et al. CURRENT HIV RESEARCH
- Mechanisms of inhibition of HIV replication by non-nucleoside reverse transcriptase inhibitors
- (2008) Nicolas Sluis-Cremer et al. VIRUS RESEARCH
- Structural basis for drug resistance mechanisms for non-nucleoside inhibitors of HIV reverse transcriptase
- (2008) Jingshan Ren et al. VIRUS RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now